| Product Code: ETC7910651 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Exocrine Pancreatic Insufficiency Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Exocrine Pancreatic Insufficiency Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Exocrine Pancreatic Insufficiency Market - Industry Life Cycle |
3.4 Latvia Exocrine Pancreatic Insufficiency Market - Porter's Five Forces |
3.5 Latvia Exocrine Pancreatic Insufficiency Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 Latvia Exocrine Pancreatic Insufficiency Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare professionals about exocrine pancreatic insufficiency (EPI) in Latvia |
4.2.2 Rising prevalence of lifestyle diseases leading to EPI, such as diabetes and cystic fibrosis |
4.2.3 Advances in diagnostic techniques for EPI diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare facilities and experts in managing EPI in Latvia |
4.3.2 High cost associated with EPI treatment and medications |
4.3.3 Lack of reimbursement policies for EPI treatment in the Latvian healthcare system |
5 Latvia Exocrine Pancreatic Insufficiency Market Trends |
6 Latvia Exocrine Pancreatic Insufficiency Market, By Types |
6.1 Latvia Exocrine Pancreatic Insufficiency Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Exocrine Pancreatic Insufficiency Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Exocrine Pancreatic Insufficiency Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.1.4 Latvia Exocrine Pancreatic Insufficiency Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.5 Latvia Exocrine Pancreatic Insufficiency Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.1.6 Latvia Exocrine Pancreatic Insufficiency Market Revenues & Volume, By Endoscopic Ultra-sonography, 2021- 2031F |
6.1.7 Latvia Exocrine Pancreatic Insufficiency Market Revenues & Volume, By Magnetic Resonance Imaging, 2021- 2031F |
6.1.8 Latvia Exocrine Pancreatic Insufficiency Market Revenues & Volume, By CT Scanning, 2021- 2031F |
7 Latvia Exocrine Pancreatic Insufficiency Market Import-Export Trade Statistics |
7.1 Latvia Exocrine Pancreatic Insufficiency Market Export to Major Countries |
7.2 Latvia Exocrine Pancreatic Insufficiency Market Imports from Major Countries |
8 Latvia Exocrine Pancreatic Insufficiency Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in EPI diagnosis and management |
8.2 Patient adherence to EPI treatment regimen |
8.3 Rate of early diagnosis of EPI cases |
8.4 Patient satisfaction with EPI treatment and care |
8.5 Number of research studies and clinical trials focused on EPI in Latvia |
9 Latvia Exocrine Pancreatic Insufficiency Market - Opportunity Assessment |
9.1 Latvia Exocrine Pancreatic Insufficiency Market Opportunity Assessment, By Type, 2021 & 2031F |
10 Latvia Exocrine Pancreatic Insufficiency Market - Competitive Landscape |
10.1 Latvia Exocrine Pancreatic Insufficiency Market Revenue Share, By Companies, 2024 |
10.2 Latvia Exocrine Pancreatic Insufficiency Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here